BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14672107)

  • 1. Men with prostate cancer: making decisions about complementary/alternative medicine.
    Boon H; Brown JB; Gavin A; Westlake K
    Med Decis Making; 2003; 23(6):471-9. PubMed ID: 14672107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
    Singh H; Maskarinec G; Shumay DM
    Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pushed and pulled: the role of affect and cognition in shaping CAM attitudes and behavior among men treated for prostate cancer.
    Porter MC; Diefenbach MA
    J Health Psychol; 2009 Mar; 14(2):288-96. PubMed ID: 19237496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of the use of alternative therapies by men with localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Patient Educ Couns; 2004 Oct; 55(1):70-7. PubMed ID: 15476992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
    Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
    Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer as part of the journey: the role of spirituality in the decision to decline conventional prostate cancer treatment and to use complementary and alternative medicine.
    White M; Verhoef M
    Integr Cancer Ther; 2006 Jun; 5(2):117-22. PubMed ID: 16685076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.
    Diefenbach MA; Hamrick N; Uzzo R; Pollack A; Horwitz E; Greenberg R; Engstrom PF
    J Urol; 2003 Jul; 170(1):166-9. PubMed ID: 12796672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
    Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
    Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
    Can G; Erol O; Aydiner A; Topuz E
    Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Religious and spiritual resources, CAM, and conventional treatment in the lives of cancer patients.
    Tatsumura Y; Maskarinec G; Shumay DM; Kakai H
    Altern Ther Health Med; 2003; 9(3):64-71. PubMed ID: 12776477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of significant others in complementary and alternative medicine decisions by cancer patients.
    Ohlén J; Balneaves LG; Bottorff JL; Brazier AS
    Soc Sci Med; 2006 Sep; 63(6):1625-36. PubMed ID: 16725245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring attitudes toward, and knowledge of, homeopathy and CAM through focus groups.
    Furnham A
    Complement Ther Nurs Midwifery; 2002 Feb; 8(1):42-7. PubMed ID: 11898909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and alternative medicine: personal preference or low cost option?
    Pagán JA; Pauly MV
    LDI Issue Brief; 2004 Feb; 10(4):1-4. PubMed ID: 15782445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing patterns of CAM use among prostate cancer patients two years after diagnosis: reasons for maintenance or discontinuation.
    Porter M; Kolva E; Ahl R; Diefenbach MA
    Complement Ther Med; 2008 Dec; 16(6):318-24. PubMed ID: 19028331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.
    Beebe-Dimmer JL; Wood DP; Gruber SB; Douglas JA; Bonner JD; Mohai C; Zuhlke KA; Shepherd C; Cooney KA
    Urology; 2004 Feb; 63(2):282-7. PubMed ID: 14972472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based patient choice: a prostate cancer decision aid in plain language.
    Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
    BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.
    Henderson JW; Donatelle RJ
    Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.
    Chan JM; Elkin EP; Silva SJ; Broering JM; Latini DM; Carroll PR
    Urology; 2005 Dec; 66(6):1223-8. PubMed ID: 16360447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empowering the cancer patient or controlling the tumor? A qualitative study of how cancer patients experience consultations with complementary and alternative medicine practitioners and physicians, respectively.
    Steinsbekk A; Launsø L
    Integr Cancer Ther; 2005 Jun; 4(2):195-200. PubMed ID: 15911932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary therapy use by cancer patients. Physicians' perceptions, attitudes, and ideas.
    O'Beirne M; Verhoef M; Paluck E; Herbert C
    Can Fam Physician; 2004 Jun; 50():882-8. PubMed ID: 15233371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.